Purnima Rao-Melacini Selected Research

Glucose (Dextrose)

1/2020

Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Purnima Rao-Melacini Research Topics

Disease

13	Stroke (Strokes) 04/2024 - 07/2010
6	Type 2 Diabetes Mellitus (MODY) 12/2023 - 01/2019
4	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 06/2014
4	Heart Failure 12/2022 - 10/2015
4	Myocardial Infarction 12/2022 - 03/2016
4	Ischemic Stroke 05/2022 - 07/2010
3	Acute Coronary Syndrome 11/2016 - 02/2010
3	Hypertension (High Blood Pressure) 08/2016 - 07/2010
2	Chagas Cardiomyopathy 01/2019 - 10/2015
2	Diabetes Mellitus 08/2016 - 07/2010
1	Human Influenza (Influenza) 12/2022
1	Pneumonia (Pneumonitis) 12/2022
1	Atrial Fibrillation 01/2022
1	Atrial Flutter (Flutter, Atrial) 01/2022
1	Cerebral Hemorrhage 01/2021
1	Erectile Dysfunction 01/2021
1	Hemorrhagic Stroke 01/2021
1	Cognitive Dysfunction 01/2020
1	Pain (Aches) 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Postoperative Pain 01/2019
1	Neuralgia (Stump Neuralgia) 01/2019
1	Venous Thromboembolism 01/2018
1	Thrombosis (Thrombus) 01/2018
1	Hemorrhage 01/2018
1	Acquired Immunodeficiency Syndrome (AIDS) 11/2016
1	Unstable Angina 11/2016
1	Ischemia 03/2016
1	Acute Kidney Injury (Acute Renal Failure) 03/2016
1	Clinical Deterioration 10/2015
1	Heart Arrest (Cardiac Arrest) 10/2015
1	Ventricular Tachycardia 10/2015
1	ST Elevation Myocardial Infarction 01/2015
1	Gestational Weight Gain 01/2013
1	Binge Drinking 07/2010

Drug/Important Bio-Agent (IBA)

5	dulaglutideIBA 01/2022 - 01/2019
3	LipidsIBA 12/2023 - 01/2013
3	Apolipoproteins B (ApoB)IBA 05/2022 - 07/2010
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2020 - 01/2019
2	ApolipoproteinsIBA 05/2022 - 08/2016
2	Insulin (Novolin)FDA Link 01/2020 - 01/2013
2	Glucagon-Like Peptide-1 ReceptorIBA 01/2019 - 01/2019
2	benzonidazole (benznidazole)IBA 01/2019 - 10/2015
1	SmokeIBA 04/2024
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2023
1	Influenza Vaccines (Influenza Vaccine)FDA Link 12/2022
1	VaccinesIBA 12/2022
1	Lipoproteins (Lipoprotein)IBA 05/2022
1	oxidized low density lipoproteinIBA 05/2022
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2021
1	SodiumIBA 01/2021
1	PotassiumIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	IncretinsIBA 01/2020
1	Pregabalin (Lyrica)FDA Link 01/2019
1	Lidocaine (Xylocaine)FDA LinkGeneric 01/2019
1	Opioid Analgesics (Opioids)IBA 01/2019
1	Dabigatran FDA Link 01/2018
1	Troponin T (Troponin T1)IBA 11/2016
1	pro-brain natriuretic peptide (1-76)IBA 11/2016
1	Clopidogrel (Plavix)FDA Link 11/2016
1	C-Reactive ProteinIBA 11/2016
1	Biomarkers (Surrogate Marker)IBA 11/2016
1	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2016
1	salicylhydroxamic acid (SHAM)IBA 03/2016
1	Triglycerides (Triacylglycerol)IBA 01/2013
1	ORALIT (ORS)IBA 07/2010

Therapy/Procedure

5	Therapeutics 12/2023 - 01/2015
3	Length of Stay 01/2017 - 06/2014
2	Subcutaneous Injections 01/2019 - 01/2019
1	Surgical Amputation (Amputations) 01/2018
1	Heart Transplantation (Grafting, Heart) 10/2015
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 10/2015
1	Percutaneous Coronary Intervention 01/2015
1	Drug Therapy (Chemotherapy) 02/2010